ISHARES BREAKTHROUGH ENVIRONMENTAL SOLUTIONS ETF

19.52

0.0000

Post-market: 19.520.00000.00%16:04 EDT

Volume:4.00

Turnover:78.73

Market Cap:3.12M

PE:-27.83

High:19.52

Open:19.52

Low:19.52

Close:19.52

Loading ...

Overview Company News Filings

{"basename":"","ssrTDKData":{"titleTemplate":"%s - Tiger Brokers","title":"Tiger Brokers | Global Stocks, Options & Futures Trading App","description":"Tiger Brokers, one-stop investment in US stocks, SGX stocks, HK stocks, A-shares & other global assets. One of the best stock trading platforms in Singapore.","keywords":"tiger brokers,tiger trade,tiger brokers singapore,broker online,stock trading in singapore,share trading singapore,brokerage firm singapore,trading app,stock broker singapore,stock trading platforms,trading account","social":{"ogDescription":"Tiger Brokers, one-stop investment in US stocks, SGX stocks, HK stocks, A-shares & other global assets. One of the best stock trading platforms in Singapore.","ogImage":"https://c1.itigergrowtha.com/portal5/static/media/og-logo.be62fbe1.png","ogUrl":"https://www-web.itiger.com/stock/ETEC/news"},"companyName":"Tiger Brokers"},"pageData":{"isMobile":false,"isTiger":false,"isTTM":true,"region":"SGP","license":"TBSG","edition":"fundamental","symbol":"ETEC","isAnalysisPage":false},"__swrFallback__":{"@#url:\"https://hq.skytigris.cn/stock_info/detail/global\",params:#delay:false,,method:\"POST\",data:#items:@#symbol:\"ETEC\",,,,,undefined,":{"symbol":"ETEC","market":"US","secType":"STK","nameCN":"ISHARES BREAKTHROUGH ENVIRONMENTAL SOLUTIONS ETF","latestPrice":19.52,"timestamp":1749240000000,"preClose":19.52,"halted":0,"volume":4,"hourTrading":{"tag":"盘后","latestPrice":19.52,"preClose":19.52,"latestTime":"16:04 EDT","volume":2,"amount":39.3672,"timestamp":1749240250991},"delay":0,"floatShares":160000,"shares":160000,"eps":-0.70147,"marketStatus":"Market Closed","change":0,"latestTime":"06-06 16:00:00 EDT","open":19.52,"high":19.52,"low":19.52,"amount":78.7322,"amplitude":0,"askPrice":0,"askSize":0,"bidPrice":0,"bidSize":0,"shortable":3,"etf":1,"ttmEps":-0.70147,"tradingStatus":0,"nextMarketStatus":{"tag":"Pre-Mkt","tradingStatus":1,"beginTime":1749456000000},"marketStatusCode":7,"adr":0,"listingDate":1680235200000,"exchange":"NASDAQ","adjPreClose":19.52,"sharesOutstanding":160000,"nav":19.698467,"aum":3151754.72,"dividendRate":0.012295,"bidAskSpread":0,"postHourTrading":{"tag":"盘后","latestPrice":19.52,"preClose":19.52,"latestTime":"16:04 EDT","volume":2,"amount":39.3672,"timestamp":1749240250991},"volumeRatio":0.025974},"@#url:\"https://hq.skytigris.cn/stock_info/fundamental/all\",params:#delay:false,,method:\"POST\",data:#items:@#symbol:\"ETEC\",,,,,undefined,":{"symbol":"ETEC","floatShares":160000,"roa":"--","roe":"--","lyrEps":-0.738594,"volumeRatio":0.025974,"shares":160000,"dividePrice":0.24,"high":19.52,"amplitude":0,"preClose":19.52,"low":19.52,"week52Low":15.7153,"pbRate":"--","psRate":"0.02","week52High":22.86,"institutionHeld":0,"latestPrice":19.52,"eps":-0.70147,"divideRate":0.012295,"volume":4,"delay":0,"ttmEps":-0.70147,"open":19.52,"prevYearClose":18.94,"prevWeekClose":19.52,"prevMonthClose":19.52,"prevQuarterClose":19.12,"fiveDayClose":19.52,"twentyDayClose":18.73,"sixtyDayClose":19.09},"$inf$@#url:\"https://stock-news.skytigris.cn/v2/news/list\",params:#symbols:\"ETEC\",pageSize:20,pageCount:1,lang_content:\"en\",edition:\"fundamental\",,,undefined,":[{"items":[{"id":"2517115618","title":"Allegro MicroSystems Board Deems ON Semiconductor's $6.9B Offer 'Inadequate'","url":"https://stock-news.laohu8.com/highlight/detail?id=2517115618","media":"Benzinga","labels":["shareholding"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2517115618?lang=en_us&edition=fundamental","pubTime":"2025-03-06 18:53","pubTimestamp":1741258435,"startTime":"0","endTime":"0","summary":"Allegro MicroSystems, Inc.  shares are trading higher premarket on Thursday after it disclosed receiving a proposalfrom ON Semiconductor Corporation  for $35.10 per share, with an implied enterprise value of $6.9 billion.The all-cash offer reflects a 57% premium over Allegro’s closing price on February 28, 2025, the last trading day before reports of onsemi’s acquisition interest surfaced.Allegro’s Board, after consulting independent financial and legal advisors, deemed onsemi’s proposal inadequate.Notably, onsemi has repeatedly sought to engage Allegro MicroSystems in discussions over the past six months.Read: ON Semiconductor Focuses On AI Chip Growth, To Cut 2,400 Jobs to Stay Competitive. ”Together, Allegro’s unique product portfolio and onsemi’s differentiated intelligent power and sensing technologies would create a diversified leader in automotive, industrial and AI data center applications.”As of December 31, 2024, ON Semiconductorheld $2.99 billion in cash and equivalents.This","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://finance.yahoo.com/news/allegro-microsystems-board-deems-semiconductors-105355778.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"shareholding","news_rank":0,"length":0,"strategy_id":0,"source":"yahoofinance","symbols":["ON","TQQQ","LU1861215975.USD","BK4512","LU0724618433.USD","LU0353189763.USD","LU1861220033.SGD","LU0353189680.USD","NVIW.SI","BK4605","LU1720051108.HKD","LU1854103824.USD","BK4141","LU1854104046.USD","LU2360107325.USD","ETEC","NQmain","LU0348723411.USD","SQQQ","LU2298322129.HKD","PSQ","LU0053671581.USD","LU1861214812.USD","LU2357305700.SGD",".IXIC","BK4585","USAW.SI","BK4134","QLD","LU1548497426.USD","TSYW.SI","LU0124384867.USD","ALGM","LU1720051017.SGD","LU2087625088.SGD","QID","IE00BD6J9T35.USD","USJW.SI","BK4588","IE00BZ199S13.USD","LU1861219969.SGD","MNQmain","LU1978683503.SGD"],"gpt_icon":1},{"id":"2504615352","title":"Immuron Travelan® continued strong sales growth","url":"https://stock-news.laohu8.com/highlight/detail?id=2504615352","media":"GlobeNewswire","labels":["dataReport"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2504615352?lang=en_us&edition=fundamental","pubTime":"2025-01-17 19:00","pubTimestamp":1737111600,"startTime":"0","endTime":"0","summary":"Sales Highlights: Global December 2024 Quarter AUD$2.5 million up 70% on prior quarter, up 249% on pcpDecember 2024 Half Year AUD$4.0 million up 70% on pcp Australia December 2024 Quarter AUD$1.9 mill","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.globenewswire.com/news-release/2025/01/17/3011321/37134/en/Immuron-Travelan-continued-strong-sales-growth.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"dataReport","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["IMRN","ETEC","BK4134","BK4139"],"gpt_icon":0},{"id":"2503523433","title":"Immuron Announces Travelan® Clinical Trial Update","url":"https://stock-news.laohu8.com/highlight/detail?id=2503523433","media":"GlobeNewswire","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2503523433?lang=en_us&edition=fundamental","pubTime":"2025-01-14 19:00","pubTimestamp":1736852400,"startTime":"0","endTime":"0","summary":"Highlights: Travelan (IMM-124E) Phase 2 Clinical Study Report submitted to the FDATravelan (IMM-124E) Phase 2 Clinical Study Statistically Significant Immunology ResultsTravelan (IMM-124E) Phase 2 Cli","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.globenewswire.com/news-release/2025/01/14/3009099/37134/en/Immuron-Announces-Travelan-Clinical-Trial-Update.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK4566","IMRN","BK4134","ETEC","BK4139","BK4207","BK4585","TD"],"gpt_icon":0},{"id":"2503924265","title":"Immuron progresses development of traveller’s diarrhea drug Travelan","url":"https://stock-news.laohu8.com/highlight/detail?id=2503924265","media":"The Market Herald","labels":["productRelease"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2503924265?lang=en_us&edition=fundamental","pubTime":"2025-01-14 12:55","pubTimestamp":1736830500,"startTime":"0","endTime":"0","summary":"Immuron Ltd  has moved through a series of development milestones for its drug Travelan: which aims at preventing contraction of traveller’s diarrhea, a disorder of the digestive tract caused by pathogenic bacteria.The company on Tuesday told investors it had submitted a Clinical Study Report to the US Food and Drug Administration  for the recently completed Phase Two study on the drug, aiming to progress to Phase Three once an ‘end of Phase Two’ meeting is arranged.The Phase Two study was a randomised, double-blind, placebo-controlled trial that sought to find out the efficacy of Travelan  in a controlled human infection model for Enterotoxigenic Escherichia Coli .According to the function of Travelan, the drug’s antibodies target and bind to ETEC antigen in the gastrointestinal tract, block LPS epitopes and therefore reduce antigen exposure, resulting in lower overall IgA and IgG antibody titers.The material provided in this article is for information only and should not be treated a","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://themarketonline.com.au/immuron-progresses-development-of-travellers-diarrhea-drug-travelan-2025-01-14/","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"productRelease","news_rank":0,"length":0,"strategy_id":0,"source":"markerherald_stock","symbols":["BK7067","BK4134","ETEC","BK7508","IMC.AU"],"gpt_icon":0},{"id":"2475522568","title":"Immuron Travelan® continued strong sales growth","url":"https://stock-news.laohu8.com/highlight/detail?id=2475522568","media":"GlobeNewswire","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2475522568?lang=en_us&edition=fundamental","pubTime":"2024-10-15 18:00","pubTimestamp":1728986400,"startTime":"0","endTime":"0","summary":"Sales Highlights:GlobalSeptember 2024 Quarter AUD$1.5 million up 13% on prior quarterAustraliaSeptember 2024 Quarter AUD$1.0 million up 3% on prior quarterNorthAmericaSeptember 2024 Quarter AUD$0.5 mi","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.globenewswire.com/news-release/2024/10/15/2962989/37134/en/Immuron-Travelan-continued-strong-sales-growth.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["IMRN","ETEC","BK4134","BK4139"],"gpt_icon":0},{"id":"2472834932","title":"NMRC Reports Results for Campylobacter Controlled Human Infection Model Study","url":"https://stock-news.laohu8.com/highlight/detail?id=2472834932","media":"GlobeNewswire","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2472834932?lang=en_us&edition=fundamental","pubTime":"2024-10-04 18:30","pubTimestamp":1728037800,"startTime":"0","endTime":"0","summary":"MELBOURNE, Australia, Oct.  04, 2024  (GLOBE NEWSWIRE) -- Immuron Limited (ASX: IMC; NASDAQ: IMRN), is an Australian based and globally integrated biopharmaceutical company that has developed two comm","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.globenewswire.com/news-release/2024/10/04/2958216/37134/en/NMRC-Reports-Results-for-Campylobacter-Controlled-Human-Infection-Model-Study.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["IMRN","ETEC","BK4134","BK4139"],"gpt_icon":0}],"pageSize":20,"totalPage":1,"pageCount":1,"totalSize":6,"code":"91000000","status":"200"}],"@#url:\"https://hq.skytigris.cn/fundamental/corporate_actions/details/ETEC\",params:#limit:5,,,undefined,":[{"date":"2024-12-17","symbol":"ETEC","amount":0.14338,"announcedDate":null,"type":"dividend","lastAmount":null,"market":"US","newRecordDate":"2024-12-17","defaultRemindTime":1734445800000,"name":"ISHARES BREAKTHROUGH ENVIRONMENTAL SOLUTIONS ETF","lastCurrency":null,"lastExecuteDate":null,"recordDate":"2024-12-20","payableDate":"2024-12-17","currency":"USD","dateTimestamp":1734411600000,"payDate":"2024-12-20"},{"date":"2024-06-11","symbol":"ETEC","amount":0.09185,"announcedDate":null,"type":"dividend","lastAmount":null,"market":"US","newRecordDate":"2024-06-11","defaultRemindTime":1718112600000,"name":"ISHARES BREAKTHROUGH ENVIRONMENTAL SOLUTIONS ETF","lastCurrency":null,"lastExecuteDate":null,"recordDate":"2024-06-17","payableDate":"2024-06-11","currency":"USD","dateTimestamp":1718078400000,"payDate":"2024-06-17"},{"date":"2023-12-20","symbol":"ETEC","amount":0.874439,"announcedDate":"2023-12-19","type":"dividend","market":"US","newRecordDate":"2023-12-21","defaultRemindTime":1703082600000,"name":"ISHARES BREAKTHROUGH ENVIRONMENTAL SOLUTIONS ETF","recordDate":"2023-12-27","payableDate":"2023-12-21","currency":"USD","dateTimestamp":1703048400000,"payDate":"2023-12-27"},{"date":"2023-06-07","symbol":"ETEC","amount":0.103437,"announcedDate":"2023-06-06","type":"dividend","market":"US","newRecordDate":"2023-06-08","defaultRemindTime":1686144600000,"name":"ISHARES BREAKTHROUGH ENVIRONMENTAL SOLUTIONS ETF","recordDate":"2023-06-13","payableDate":"2023-06-08","currency":"USD","dateTimestamp":1686110400000,"payDate":"2023-06-13"}],"@#url:\"https://hq.skytigris.cn/fundamental/dividend/history\",params:#symbol:\"ETEC\",market:\"US\",,,undefined,":[{"executeDate":"2023-06-07","recordDate":"2023-06-08","paymentDate":"2023-06-13","value":0.103437,"currency":"USD"},{"executeDate":"2023-12-20","recordDate":"2023-12-21","paymentDate":"2023-12-27","value":0.874439,"currency":"USD"},{"executeDate":"2024-06-11","recordDate":"2024-06-11","paymentDate":"2024-06-17","value":0.09185,"currency":"USD"},{"executeDate":"2024-12-17","recordDate":"2024-12-17","paymentDate":"2024-12-20","value":0.14338,"currency":"USD"}],"@#url:\"https://hq.skytigris.cn/fundamental/estimate/recommendation\",params:#symbol:\"ETEC\",market:\"US\",delay:false,,,undefined,":{}}}